PhRMA to review efficacy of drugs in study

WASHINGTON Several drug makers and an industry trade group representing them will fund a two-year study to examine the safety and efficacy of drugs on the market, according to published reports.

The Pink Sheet reported that the Pharmaceutical Research and Manufacturers of America would help fund the public-private study through the Foundation for the National Institutes of Health.

Known as the Observational Medical Outcomes Partnership, the initiative began in 2009, with Food and Drug Administration Center for Drug Evaluation and Research director Janet Woodcock serving as executive board chair.